We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GLPG

Price
31.12
Stock movement up
+0.07 (0.23%)
Company name
Galapagos NV ADR
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
2.05B
Ent value
3.23B
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
9.94
Forward P/E
268.28
PEG
-
EPS growth
-
1 year return
23.39%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-25

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

GLPG does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E9.94
Price to OCF-
Price to FCF-
Price to EBITDA108.86
EV to EBITDA171.27

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-359.68

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count65.90M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)0.12

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open30.99
Daily high31.27
Daily low30.89
Daily Volume85K
All-time high274.03
1y analyst estimate30.59
Beta-0.05
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date24 Feb 2026

Downside potential

Loading...
Downside potential data
GLPGS&P500
Current price drop from All-time high-88.64%-1.80%
Highest price drop-91.72%-19.00%
Date of highest drop4 Feb 20258 Apr 2025
Avg drop from high-89.55%-2.73%
Avg time to new high-6 days
Max time to new high284 days89 days
COMPANY DETAILS
GLPG (Galapagos NV ADR) company logo
Marketcap
2.05B
Marketcap category
Mid-cap
Description
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Employees
704
Investor relations
-
SEC filings
CEO
Onno van de Stolpe
Country
USA
City
Mechelen
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...